N-12
NDC 58264-0210, Phosphoric Acid, Cinchona officinalis Bark, Anemone pulsatilla, Phosphorus, Picric acid, Magnesium Phosphate, Dibasic Trihydrate, Viburnum opulus Whole, Bos taurus pituitary gland, posterior, Bos taurus ovary, Bos taurus adrenal gland, and Thyroid, Unspecified, solution, from DNA Labs, Inc..
- Product NDC
- 58264-0210
- Status
- Listed
- Labeler
- DNA Labs, Inc.
- Dosage form
- SOLUTION
- Route
- SUBLINGUAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Application
- —
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/58264-0210 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- PHOSPHORIC ACID6 [hp_X]/mL
- CINCHONA OFFICINALIS BARK6 [hp_X]/mL
- ANEMONE PULSATILLA6 [hp_X]/mL
- PHOSPHORUS6 [hp_X]/mL
- PICRIC ACID6 [hp_X]/mL
- MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE6 [hp_X]/mL
- VIBURNUM OPULUS WHOLE2 [hp_X]/mL
- BOS TAURUS PITUITARY GLAND, POSTERIOR200 [hp_X]/mL
- BOS TAURUS OVARY200 [hp_X]/mL
- BOS TAURUS ADRENAL GLAND200 [hp_X]/mL
- THYROID, UNSPECIFIED200 [hp_X]/mL
Pharmacologic classes
Calculi Dissolution Agent [EPC]; Increased Large Intestinal Motility [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]; Magnesium Ion Exchange Activity [MoA]; Osmotic Activity [MoA]; Osmotic Laxative [EPC]; Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 58264-0210-1 | 58264021001 | 29.57 mL in 1 BOTTLE, GLASS (58264-0210-1) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 58264-0210 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/58264-0210 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 58264-0210. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.